You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hypomethylation

Showing 1 - 25 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Minimal Residual Disease Trial (Venetoclax, Decitabine,

Not yet recruiting
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Venetoclax, Decitabine, Azacytidine, Cytarabine
  • (no location specified)
May 4, 2022

MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Denmark (Vitamin C, Placebo)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Vitamin C
  • Placebo
  • Aalborg, Denmark
  • +5 more
Sep 27, 2021

Obesity, Vascular Dysfunction Trial in Chicago (Exercise training)

Recruiting
  • Obesity
  • Vascular Dysfunction
  • Exercise training
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 8, 2021

Obesity Trial in Bangkok (Fermented Vegetables (Kimchi) supplementation, probiotic, polyphenol)

Not yet recruiting
  • Obesity
  • Fermented Vegetables (Kimchi) supplementation
  • +2 more
  • Bangkok, Thailand
    Jintana Sirivarasai
Jun 15, 2023

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

Recruiting
  • Recurrent IDH1/2 Mutated Glioma
  • Paris, France
    Pitie Salpetriere Hospital
Aug 29, 2022

Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)

Recruiting
  • Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
  • TQB2618 injection azacitidine, AZA decitabine, DAC
  • ChengDu, Sichuan, China
    West China Hospital of Sichuan University
Jun 16, 2022

Exploratory Study of Rectal Mucus for Diagnosing Disease

Completed
  • Bowel Cancer
  • +3 more
    • Truro, Cornwall, United Kingdom
    • +3 more
    Aug 15, 2022

    MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
    • Defactinib
    • Sydney, New South Wales, Australia
    • +3 more
    Jan 12, 2023

    Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)

    Recruiting
    • Acute Myeloid Leukemia
    • CAV Regimen
    • MEC Regimen
    • Suzhou, Jiangsu, China
      The First Affliated Hospital of Soochow University
    Dec 22, 2022

    Agricultural Health Study Cohort Pesticide Exposure Study

    Completed
    • Multiple Myeloma
    • +3 more
      • Iowa City, Iowa
      • +1 more
      Jan 25, 2023

      Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)

      Recruiting
      • Malignant Melanoma
      • Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
      • Aurora, Colorado
        University of Colorado Hospital
      May 25, 2022

      Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

      Not yet recruiting
      • Ovarian Cancer
      • Maywood, Illinois
        Loyola University Medical Center
      Aug 1, 2023

      MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

      Recruiting
      • MDS/MPN
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Jun 20, 2022

      FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

      Active, not recruiting
      • FLT3 Gene Mutation Negative
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 16, 2022

      Exposure to Environmental Pollution Trial in Toulouse (Sampling on surgery day)

      Recruiting
      • Exposure to Environmental Pollution
      • Sampling on surgery day
      • Toulouse, France
        CHU Toulouse
      Nov 14, 2022

      Detecting Epigenetic Imprinting Alterations in Bronchoalveolar

      Recruiting
      • Lung Cancer
      • Quantitative Chromogenic Imprinted Gene in situ Hybridization (QCIGISH)
      • Nanjing, Jiangsu, China
      • +2 more
      Jan 29, 2023

      Myeloid Tumor Trial in Suzhou (IBI322, HMA)

      Not yet recruiting
      • Myeloid Tumor
      • Suzhou, Jiangsu, China
        The first affiliated hospital of soochow university
      Nov 25, 2021

      Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States (Cytarabine,

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +9 more
      • Brewer, Maine
      • +8 more
      Jun 18, 2021

      Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)

      Recruiting
      • Acute Monocytic Leukemia
      • Newly Diagnosed
      • Suzhou, Jiangsu, China
        The First Affliated Hospital of Soochow University
      Oct 3, 2022

      Increase Diagnostics Efficiency of Autism Spectrum Disorder

      Recruiting
      • Autism Spectrum Disorder
      • Salivary collection
      • +2 more
      • Messina, Italy
        IRCCS Centro Neurolesi Bonino Pulejo
      Mar 30, 2023

      MDS Trial in New Haven (CPX-351)

      Withdrawn
      • MDS
      • New Haven, Connecticut
        Yale University; Smilow Cancer Center
      Jan 6, 2022

      Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

      Completed
      • Acute Myelogenous Leukemia
      • Los Angeles, California
      • +32 more
      Jun 22, 2022

      Ischemic Complication During the TAVR Procedure in the Elderly

      Recruiting
      • Cognitive Decline
      • Stroke
        • Lille, France
          Hôpital cardiologie, CHRU
        Jan 31, 2022